-
Press Release
Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
-
Press Release
Novartis to launch Direct-to-Patient platform for Cosentyx® (secukinumab) in the US
-
Press Release
Novartis ranks first in 2024 Access to Medicine Index
-
Story
Negative impact of the IRA on patient access to innovative treatments -
Story
Sickle cell screening urged for newborns in Africa -
Story
Boosting access to cancer care where it’s needed most -
Story
Prioritizing the needs of patients -
Press Release
Novartis accelerates efforts toward ESG targets to increase access to medicines, improve health equity and achieve net-zero carbon emissions
-
Press Release
Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts
-
Story
Teaching a daughter the power of purpose -
Press Release
Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
-
Story
Meet a visionary who beat the odds to realize his vision of inclusive eye care